The Economics and Implementation Research Group (EIRG)
Within MAEMOD, the Economics and Implementation Research Group (EIRG) seeks to bridge the gap between cutting edge health research and health policy and reduce the lead-in time between scientific results and implementation.
The Group primarily works on health technology evaluations in real-life settings. Group members explore the cost-effectiveness of new interventions and their clinical, social and ethical implications, in close collaboration with relevant MORU departments and units.
The Group seeks to strengthen collaborations with policy makers and stakeholders to ensure that research questions being studied are of the greatest policy relevance and likely to feed directly into implementation and the patient’s benefit. The recent establishment of a sub-unit within the Department of Medical Research (DMR) in Yangon, for example, facilitated the interaction between our health economics and modelling work and led to outputs being directly provided to the DMR and the Myanmar national malaria control programme.
One of the group’s current main focuses is evaluating biomarker tests for use in remote rural tropical settings. Building on recent laboratory based retrospective studies and field evaluation of CRP rapid tests, this will result in a randomized control trial for CRP guided treatment of febrile patients in primary care.
Besides its own research, EIRG also supports health economic studies and early career researchers across the Major Overseas Programme centres in Southeast Asia.
The eight-person group currently consists of three health economists, three clinicians, a social scientist and a data analyst, with four research nurses to be soon hired for the upcoming clinical trial.
Yoel Lubell, EIRG Group Head & University Research Lecturer
Angela Devine, Research Fellow & PhD Student
Thomas Althaus, Clinical Trial Coordinator
Shwe Sin Kyaw, PhD Student
Win Thu, Health Economist
Sai Thein Than Tun, PhD Student